Utpal Bhagirath Pajvani, MD

Academic Appointments

  • Assistant Professor of Medicine
Utpal Bhagirath Pajvani, MD

Dr. Utpal Pajvani, Associate Professor of Medicine in the Division of Endocrinology at Columbia University, is a physician-scientist with clinical and research focus in Type 2 Diabetes and related metabolic diseases. He graduated from the Massachusetts Institute of Technology with a degree in Biology in 1996, then earned M.S. (2001), M.D. (2005) and Ph.D. (Department of Cell Biology, 2005) degrees from the Albert Einstein College of Medicine. Dr. Pajvani completed his internship and residency training and is board certified in Internal Medicine (2007) and fellowship in Endocrinology, Diabetes & Metabolism (2011), both at the Columbia University Medical Center.

Dr. Pajvani has been on the faculty of Columbia University since 2011. He is a teaching attending on the inpatient and outpatient Endocrinology and General Medicine services of the New York Presbyterian Hospital, and sees patients at the Naomi Berrie Diabetes Center at Columbia University. Dr. Pajvani’s research focuses on the role of developmental pathways in the regulation of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease, and the use of existing therapeutic agents in other scientific areas in novel applications to ameliorate obesity-induced complications including cancer. He has received intramural and NIH support for his research, and has mentored medical and graduate students as well as postdoctoral and clinical fellows.

Dr. Utpal Pajvani's current research focuses on the role of developmental pathways in the regulation of Type 2 Diabetes, and the use of existing therapeutic agents in other scientific areas in novel applications to ameliorate obesity-induced insulin resistance. Dr. Pajvani sees patients at the Naomi Berrie Diabetes Center, and attends on the inpatient Endocrinology consult service and outpatient General Endocrine clinic at the Columbia University Medical Center. 

Departments and Divisions

  • Department of Medicine
    Division of Endocrinology

Board Certifications

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Areas of Expertise

  • Diabetes

Education and Training

  • Albert Einstein College of Medicine of Yeshiva University
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Locations

  • CUIMC/Russ Berrie Medical Science Pavilion

    1150 St. Nicholas Avenue
    New York, NY 10032
    Phone:
    (212) 851-5494

Centers / Institutes / Programs

  • Institute of Human Nutrition

Provider Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Insurance Programs

Please contact the provider's office directly to verify that your particular insurance is accepted.

  • AETNA [Aetna Signature Administrators, EPO, HMO, Medicare Managed Care, NYP Employee Plan, NY Signature, POS, PPO, Student Health]
  • Affinity Health Plan [Essential Plan, Medicaid Managed Care]
  • AgeWell [Medicare Managed Care, Special Needs]
  • Amida Care [Special Needs]
  • CIGNA [EPO, Great West (National), HMO, POS, PPO]
  • Emblem/GHI [Medicare Managed Care, PPO]
  • Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
  • Empire Blue Cross/Blue Shield [EPO, HMO, Medicare Managed Care, PPO]
  • Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
  • Fidelis Care [Child/Family Health Plus, Essential Plan, Medicaid Managed Care, Medicare Managed Care]
  • Healthfirst [Child/Family Health Plus, Leaf (Exchange), Medicaid Managed Care, Medicare Managed Care]
  • Local 1199 [Local 1199]
  • MagnaCare (National) [MagnaCare]
  • Medicare [Railroad, Traditional Medicare]
  • Multiplan [Multiplan]
  • MVP Health Care [Child/Family Health Plus, Essential Plan, HMO, Medicaid Managed Care]
  • Oxford Health Plans [Freedom, Liberty]
  • RiverSpring [Special Needs]
  • UnitedHealthcare [Compass (Exchange), Empire Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]
  • VNSNY CHOICE [Medicare Managed Care, SelectHealth, Special Needs]
  • WellCare [Medicaid Managed Care, Medicare Managed Care]

This provider accepts new patients

Appointment Phone Number: (212) 851-5494

Lab Locations

  • CUIMC/Russ Berrie Medical Science Pavilion

    1150 St. Nicholas Avenue
    New York, NY 10032

Honors and Awards

  • White House Presidential Scholar's Award (1993)
  • Rensselaer Polytechnic Institute Medal for Math and Science (1993)
  • Sigma Xi Scientific Research Society Award (1997)
  • Julius Marmur Research Award (2004)
  • Alpha Omega Alpha (2005)
  • Keystone Symposium Travel Award (2009)
  • ADA Travel Award (2009)

NIH Grants

  • NOTCH,TYPE 2 DIABETES AND NAFLD (Federal Gov)

    Jun 1 2020 - Mar 31 2024

    JAGGED-NOTCH SIGNALING IN NASH/FIBROSIS (Federal Gov)

    Feb 15 2019 - Jan 31 2023

    ROLE OF GAMMA-SECRETASE IN DYSLIPIDEMIA AND ATHEROSCLEROSIS (Private)

    Jul 1 2017 - Jun 30 2020

    NOTCH,TYPE 2 DIABETES AND NAFLD (Federal Gov)

    Jul 1 2015 - May 31 2020

    UNRAVELING THE ROLE OF NOTCH SIGNALING IN ADULT PANCREATIC BETA CELL (Private)

    Jan 1 2017 - Dec 31 2019

    NANOPARTICLE NOTCH INHIBITORS TO TREAT OBESITY-INDUCED HEPATIC INSULIN RESISTANCE AND NON-ALCOHOLICSTEATOHEPATITIS (Private)

    Jan 1 2019 - Dec 31 2019

    INVESTIGATE THE JAGGED1-NOTCH-OSTEOPONTIN AXIS IN NON-ALCOHOLIC STEATOHEPATITIS AND FIBROSIS (Private)

    Jan 1 2017 - Dec 31 2018

    GLYCEMIA REDUCTION APPROACHES IN DIABETES: A COMPARATIVE EFFECTIVENESS (GRADE) STUDY (Federal Gov)

    Sep 6 2017 - Jul 31 2018

    JAGGED-NOTCH SIGNALING IN NASH/FIBROSIS (Federal Gov)

    Dec 20 2016 - Dec 19 2017

    JAGGED-NOTCH SIGNALING IN NASH/FIBROSIS (Private)

    Dec 20 2016 - Dec 19 2017

    HEPATOCYLE NOTCH SIGNALING REGULATES NASH (Federal Gov)

    Apr 1 2015 - Mar 31 2017

    NOTCH AND REGULATORS OF NOTCH SIGNALING IMPACT BOTH GLUCOSE AND LIPID (Federal Gov)

    Sep 15 2011 - Jul 31 2016

    NOTCH AND REGULATORS OF NOTCH SIGNALING IMPACT BOTH GLUCOSE AND LIPID (Federal Gov)

    Sep 15 2011 - Jul 31 2016

    NOTCH AND REGULATORS OF NOTCH SIGNALING IMPACT BOTH GLUCOSE AND LIPID (Federal Gov)

    Sep 15 2011 - Jul 31 2016

    NOTCH REGULAT4D HEPATIC GLUCOSE AND LIPID METABOLISM (Private)

    Oct 1 2012 - Sep 30 2013